Sharon Batt - Adjunct Professor, Independent Researcher and Writer
Sharon () entered a doctoral program at HÂþ» as an Interdisciplinary PhD student with a CIHR fellowship in the CIHR Training Program in Ethics of Health Research and Policy. She conducted her PhD research under Dr. Janice Graham’s supervision and graduated in May 2012. Her dissertation, a study of the policy implications of pharmaceutical company funding of patients' groups, was awarded the HÂþ» University Faculty of Graduate Studies Doctoral Thesis Award for the university's most outstanding doctoral thesis in the humanities and social sciences. She is currently finalizing a book manuscript based on this research. She is a member of Dr. Graham's Technoscience and Regulation Research Unit (TRRU) at HÂþ» and had a 2012 fellowship from the .
Before returning to graduate school, Sharon worked as a journalist and community activist, work that informs her scholarly research. Following a cancer diagnosis in 1988, she co-founded the organization . Her book (Gynergy Press), published in 1994, won the 1995 Laura Jamieson Award for the best feminist book published in Canada. Her work in breast cancer politics led her to broader activism in the women's health movement, environmental health, and pharmaceutical policy. In 1999 she was awarded a two-year appointment to the at Mount Saint Vincent University in Halifax and from 2001 to 2003 she held the Elizabeth May Chair in Women's Health and the Environment at HÂþ» University. Since 1998 she has been on the steering committee of , a coalition of community groups, journalists, and academics concerned about the safety of pharmaceutical drugs. She contributed three chapters to the book published in 2010 (Women's Press).
A book chapter based on her dissertation research appears in the edited collection The Public Shaping of Medical Research: Patient Associations, Health Movements and Biomedicine (Routledge) in 2015 (reviewed in).
A review essay on corruption in the pharmaceutical industry and the moral crisis in medicine is forthcoming in the Hastings Center Report in 2016.
Sharon Batt, PhD
Researcher and Writer, Health & Pharmaceutical Policy, TRRU